December 07, 2018
Rose
A Swiss drugmaker is challenging a 2011 change to the law that no longer allows a company to patent an invention if it was for sale for more than a year before filing a patent application. Meanwhile, Congress also plans to focus on the issue of pharmaceutical patents and lawmakers continue to question the industry's pricing decisions. And as Capitol Hill gears up for potential action on drug costs, there may be some lessons to be learned from China.
from Kaiser Health News https://ift.tt/2G6Oa5v
December 07, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Fewer Traffic Collisions During Shutdown Means Longer Waits For Organ Donations- The Pandemic Is Hurting Pediatric Hospitals, Too
- ‘Last Responders’ Seek To Expand Postmortem COVID Testing In Unexplained Deaths
- Tourists, Beware: Foreign Visitors’ Travel Health Insurance Might Exclude Pandemics
- Proveedores de Medicaid, al final de la lista para recibir fondos por COVID
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment